Heart protein levels and irregular heartbeat ablation study
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at a protein in your blood called BDNF and how it relates to heart muscle changes in people having their first ablation procedure for persistent atrial fibrillation (a common type of irregular heartbeat). Researchers want to understand if this protein might help predict who will benefit most from the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are scheduled for your first ablation procedure for persistent atrial fibrillation at Dijon Bourgogne University Hospital
- You are enrolled in or eligible for a French social security program
- You are able to give your own informed consent (not under legal guardianship or court protection)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This trial is testing a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which treats atrial fibrillation (a type of irregular heartbeat). It is for people who are having this procedure for the first time and whose heart is in a normal rhythm at the time of treatment.
This study follows patients getting a newer heart rhythm treatment called pulsed field ablation for atrial fibrillation (an irregular heartbeat). Researchers want to understand which patients do well long-term and which may need additional treatment.
Hear when a new Atrial Fibrillation Ablation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.